drugset / Trial / NCT01089738
A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals
RandomizedSequentialDouble-blindOther
Summary
This study is designed to look at the safety and blood concentrations of PF-03382792 in healthy elderly subjects after taking multiple doses for 14 days.
Timeline
- Start
- 2010-11-01
- Primary completion
- 2011-04-25
- Completion
- 2011-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03382792 | Small molecule | 0.5 mg | — |
| Subject | PF-03382792 | Small molecule | 1.5 mg | — |
| Subject | PF-03382792 | Small molecule | 5 mg | — |
| Subject | PF-03382792 | Small molecule | 15 mg | — |
Indications
No indication recorded.